Table 5 Results and patterns of patients with/without anti-Ro52/tripartite motif-containing 21 antibodies (anti-Ro52).
Subjects | All | Anti-Ro52 positive | Anti-Ro52 negative | P value |
|---|---|---|---|---|
n = 288 n (%) | n = 20 n (%) | n = 268 n (%) | ||
HRCT findings | ||||
Volume loss | 201 (70) | 17 (85) | 184 (69) | 0.10 |
Lower distribution | 201 (70) | 18 (90) | 183 (69) | 0.03 |
Subpleural distribution | 200 (69) | 13 (65) | 187 (70) | 0.41 |
Peribronchial distribution | 40 (14) | 3 (15) | 37 (14) | 0.55 |
Reticular shadow | 241 (84) | 18 (90) | 223 (84) | 0.34 |
Honeycombing | 110 (38) | 10 (50) | 100 (38) | 0.19 |
Traction bronchiectasis | 228 (79) | 19 (95) | 209 (79) | 0.052 |
Ground-glass attenuation | 200 (69) | 9 (45) | 191 (72) | 0.02 |
Consolidation | 88 (31) | 4 (20) | 84 (32) | 0.21 |
Thickening of BVB | 7 (2) | 1 (5) | 6 (2) | 0.40 |
Small nodules (φ < 5 mm) | 17 (6) | 0 (0) | 17 (6) | 0.28 |
Nodules (φ > 5 mm) | 13 (5) | 1 (5) | 12 (5) | 0.62 |
Pleural effusion | 14 (5) | 0 (0) | 14 (5) | 0.36 |
HRCT pattern | ||||
UIP | 120 (42) | 9 (45) | 111 (42) | 0.46 |
NSIP | 91 (32) | 9 (45) | 82 (31) | 0.14 |
OP | 31 (11) | 0 (0) | 31 (12) | 0.09 |
DAD | 11 (4) | 0 (0) | 11 (4) | 0.45 |
Others | 35 (12) | 2 (10) | 33 (12) | 0.55 |
